Dr. Toukam joined Certara in March 2020. She holds a PhD in Pharmaceutical Sciences from Texas Southern University where her research activities focused on preclinical development of OJT008, a novel compound that target methionine aminopeptidase for the treatment of leishmaniasis. Prior to joining Certara, Dr. Toukam worked as a Senior Pharmacokinetics Scientist at Synteract in Morrisville NC where she was involved in pre-clinical and clinical studies performing NCA, PK/PD analyses using Phoenix WinNonlin and NLME. She has tremendous preclinical and clinical drug development experience that includes design, pre-formulations and formulation studies, data analysis, interpretation and reporting of pharmacokinetics (PK)/ pharmacodynamics (PD) as well as drug-drug interaction studies. She has successfully worked in cross-functional teams including bio-analytics, biometrics, clinical development, drug discovery and regulatory affairs for the conduct and interpretation of preclinical and clinical studies. Dr. Toukam current principal interests are pharmacokinetics and pharmacodynamics modeling, linear and nonlinear mixed-effects modeling.